166 related articles for article (PubMed ID: 19732414)
1. Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study.
Jansen SA; Conzen SD; Fan X; Markiewicz EJ; Newstead GM; Karczmar GS
Breast Cancer Res; 2009; 11(5):R65. PubMed ID: 19732414
[TBL] [Abstract][Full Text] [Related]
2. MRI accurately identifies early murine mammary cancers and reliably differentiates between in situ and invasive cancer: correlation of MRI with histology.
Mustafi D; Zamora M; Fan X; Markiewicz E; Mueller J; Conzen SD; Karczmar GS
NMR Biomed; 2015 Sep; 28(9):1078-86. PubMed ID: 26152557
[TBL] [Abstract][Full Text] [Related]
3. Mammary cancer initiation and progression studied with magnetic resonance imaging.
Fan X; Mustafi D; Markiewicz E; Zamora M; Vosicky J; Leinroth A; Mueller J; Macleod K; Conzen SD; Karczmar GS
Breast Cancer Res; 2014 Dec; 16(6):495. PubMed ID: 25510596
[TBL] [Abstract][Full Text] [Related]
4. In vivo MRI of early stage mammary cancers and the normal mouse mammary gland.
Jansen SA; Conzen SD; Fan X; Markiewicz E; Krausz T; Newstead GM; Karczmar GS
NMR Biomed; 2011 Aug; 24(7):880-7. PubMed ID: 21264977
[TBL] [Abstract][Full Text] [Related]
5. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.
Green JE; Shibata MA; Yoshidome K; Liu ML; Jorcyk C; Anver MR; Wigginton J; Wiltrout R; Shibata E; Kaczmarczyk S; Wang W; Liu ZY; Calvo A; Couldrey C
Oncogene; 2000 Feb; 19(8):1020-7. PubMed ID: 10713685
[TBL] [Abstract][Full Text] [Related]
6. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
[TBL] [Abstract][Full Text] [Related]
7. A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland.
Schulze-Garg C; Löhler J; Gocht A; Deppert W
Oncogene; 2000 Feb; 19(8):1028-37. PubMed ID: 10713686
[TBL] [Abstract][Full Text] [Related]
8. Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation.
Jansen SA; Conzen SD; Fan X; Krausz T; Zamora M; Foxley S; River J; Newstead GM; Karczmar GS
Phys Med Biol; 2008 Oct; 53(19):5481-93. PubMed ID: 18780960
[TBL] [Abstract][Full Text] [Related]
9. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Maglione JE; McGoldrick ET; Liu S; Wurz GT; DeGregorio MW; Borowsky AD; MacLeod CL; Cardiff RD; Gregg JP
Breast Cancer Res; 2005; 7(6):R881-9. PubMed ID: 16280035
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
[TBL] [Abstract][Full Text] [Related]
11. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.
Shibata MA; Maroulakou IG; Jorcyk CL; Gold LG; Ward JM; Green JE
Cancer Res; 1996 Jul; 56(13):2998-3003. PubMed ID: 8674054
[TBL] [Abstract][Full Text] [Related]
12. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.
Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE
Oncogene; 2001 Apr; 20(16):2044-9. PubMed ID: 11360188
[TBL] [Abstract][Full Text] [Related]
13. Mammary Tumor Growth and Proliferation Are Dependent on Growth Hormone in Female SV40 C3(1) T-Antigen Mice.
Unterberger CJ; McGregor SM; Kopchick JJ; Swanson SM; Marker PC
Endocrinology; 2022 Dec; 164(2):. PubMed ID: 36269749
[TBL] [Abstract][Full Text] [Related]
14. Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model.
Jansen SA; Paunesku T; Fan X; Woloschak GE; Vogt S; Conzen SD; Krausz T; Newstead GM; Karczmar GS
Radiology; 2009 Nov; 253(2):399-406. PubMed ID: 19864527
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer.
Hensley H; Quinn BA; Wolf RL; Litwin SL; Mabuchi S; Williams SJ; Williams C; Hamilton TC; Connolly DC
Cancer Biol Ther; 2007 Nov; 6(11):1717-25. PubMed ID: 17986851
[TBL] [Abstract][Full Text] [Related]
16. Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions.
Oakes SR; Robertson FG; Kench JG; Gardiner-Garden M; Wand MP; Green JE; Ormandy CJ
Oncogene; 2007 Jan; 26(4):543-53. PubMed ID: 16862169
[TBL] [Abstract][Full Text] [Related]
17. The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer.
Shibata MA; Jorcyk CL; Liu ML; Yoshidome K; Gold LG; Green JE
Toxicol Pathol; 1998; 26(1):177-82. PubMed ID: 9502400
[No Abstract] [Full Text] [Related]
18. Correlation of In Vivo and Ex Vivo ADC and T2 of In Situ and Invasive Murine Mammary Cancers.
Fan X; Macleod K; Mustafi D; Conzen SD; Markiewicz E; Zamora M; Vosicky J; Mueller J; Karczmar GS
PLoS One; 2015; 10(7):e0129212. PubMed ID: 26208092
[TBL] [Abstract][Full Text] [Related]
19. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.
Kupferman ME; Fini ME; Muller WJ; Weber R; Cheng Y; Muschel RJ
Am J Pathol; 2000 Dec; 157(6):1777-83. PubMed ID: 11106549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
